rs797045691

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS2_SupportingBS1

This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Pro399Ser variant in MECP2 (NM_004992.3) is 0.01% in Latino/Admixed American sub population in gnomAD, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro399Ser variant is observed in 1 unaffected individual (internal database) (BS2_supporting). In summary, the p.Pro399Ser variant in MECP2 is classified as a Likely Benign based on the ACMG/AMP criteria (BS1, BS2_supporting). LINK:https://erepo.genome.network/evrepo/ui/classification/CA206184/MONDO:0010726/016

Frequency

Genomes: 𝑓 0.000037 ( 0 hom., 1 hem., cov: 20)
Exomes 𝑓: 0.000015 ( 0 hom. 2 hem. )

Consequence

MECP2
NM_001110792.2 missense

Scores

1
2
14

Clinical Significance

Likely benign reviewed by expert panel U:2B:2

Conservation

PhyloP100: 2.54
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BS1
BS2

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MECP2NM_001110792.2 linkuse as main transcriptc.1231C>T p.Pro411Ser missense_variant 3/3 ENST00000453960.7
MECP2NM_004992.4 linkuse as main transcriptc.1195C>T p.Pro399Ser missense_variant 4/4 ENST00000303391.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MECP2ENST00000453960.7 linkuse as main transcriptc.1231C>T p.Pro411Ser missense_variant 3/31 NM_001110792.2 P51608-2
MECP2ENST00000303391.11 linkuse as main transcriptc.1195C>T p.Pro399Ser missense_variant 4/41 NM_004992.4 P1P51608-1
MECP2ENST00000407218.5 linkuse as main transcriptc.*567C>T 3_prime_UTR_variant 4/45
MECP2ENST00000628176.2 linkuse as main transcriptc.*567C>T 3_prime_UTR_variant 5/53

Frequencies

GnomAD3 genomes
AF:
0.0000370
AC:
4
AN:
107981
Hom.:
0
Cov.:
20
AF XY:
0.0000329
AC XY:
1
AN XY:
30351
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000983
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000580
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000171
AC:
3
AN:
175912
Hom.:
0
AF XY:
0.0000311
AC XY:
2
AN XY:
64370
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000366
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000254
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000146
AC:
16
AN:
1093362
Hom.:
0
Cov.:
33
AF XY:
0.00000554
AC XY:
2
AN XY:
360762
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000284
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000178
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000370
AC:
4
AN:
107981
Hom.:
0
Cov.:
20
AF XY:
0.0000329
AC XY:
1
AN XY:
30351
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000983
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000580
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000302
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:2Benign:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 08, 2013- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 07, 2018The p.P399S variant (also known as c.1195C>T), located in coding exon 3 of the MECP2 gene, results from a C to T substitution at nucleotide position 1195. The proline at codon 399 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and serine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Severe neonatal-onset encephalopathy with microcephaly Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeMar 14, 2023- -
Rett syndrome Benign:1
Likely benign, reviewed by expert panelcurationClinGen Rett and Angelman-like Disorders Variant Curation Expert PanelDec 09, 2022The allele frequency of the p.Pro399Ser variant in MECP2 (NM_004992.3) is 0.01% in Latino/Admixed American sub population in gnomAD, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). The p.Pro399Ser variant is observed in 1 unaffected individual (internal database) (BS2_supporting). In summary, the p.Pro399Ser variant in MECP2 is classified as a Likely Benign based on the ACMG/AMP criteria (BS1, BS2_supporting). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
17
DANN
Benign
0.65
DEOGEN2
Benign
0.22
T;.
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.85
D;D
M_CAP
Pathogenic
0.45
D
MetaRNN
Benign
0.097
T;T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
-0.90
N;.
MutationTaster
Benign
0.71
D;D
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
1.2
N;N
REVEL
Benign
0.26
Sift
Benign
0.45
T;T
Sift4G
Benign
0.32
T;T
Polyphen
0.0010
B;B
Vest4
0.057
MutPred
0.27
Gain of phosphorylation at P399 (P = 7e-04);.;
MVP
0.88
ClinPred
0.048
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.085
gMVP
0.21

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs797045691; hg19: chrX-153296084; API